Table 1.
Metabolites used in the biomarker panel developed by CDC National Center for Environmental Health
Biomarker Class | Full compound name | Parent compound | Abbreviation | CV (%) |
---|---|---|---|---|
Nicotine and its metabolites | cotinine | Nicotine | COTT1 | 4.6 |
trans-3'-hydroxycotinine | Nicotine | HCTT1 | 4.3 | |
cotinine N-oxide | Nicotine | COXT2 | 7.3 | |
norcotinine | Nicotine | NCTT2 | 6.7 | |
nicotine | Nicotine | NICT2 | 2.5 | |
nicotine 1'-oxide | Nicotine | NOXT2 | 5.0 | |
nornicotine | Nicotine | NNCT2 | 3.7 | |
Other tobacco alkaloids | anabasine | Anabasine | ANBT2 | 3.1 |
anatabine | Anatabine | ANTT2 | 3.9 | |
Tobacco specific nitrosamines (TSNAs) | N′-nitrosoanabasine | NAB | NABT2 | 4.1 |
N′-nitrosoanatabine | NAT | NATT2 | 4.6 | |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol | NNK | NNAL2 | 1.4 | |
N′-nitrosonornicotine | NNN | NNNT2 | 13.7 | |
Metabolites of polycyclic aromatic hydrocarbons (PAHs) | 1 -Hydroxynaphthalene | Naphthalene/carbaryl* | 1-nap1 | 2.2 |
2-Hydroxynaphthalene | Naphthalene | 2-nap1 | 2.9 | |
1 -Hydroxyphenanthrene | Phenanthrene | 1-phe1 | 7.5 | |
Sum of 2- and 3-hydroxyphenanthrene | Phenanthrene | ∑2,3phe1 | 6.9 | |
2-Hydroxyfluorene | Fluorene | 2-flu1 | 3.1 | |
3-Hydroxyfluorene | Fluorene | 3-flu1 | 5.7 | |
1 -Hydroxypyrene | Pyrene | 1-pyr1 | 20.1 | |
Metabolites of volatile organic compounds (VOCs) | 2-Methylhippuric acid | Xylene | 2MHA1 | 7.4 |
3-Methylhippuric acid + 4 Methylhippuric acid | Xylene | 34MH1 | 10.8 | |
N-Acetyl-S-(2-carbamoylethyl)-L-cysteine | Acrylamide | AAMA1 | 13.5 | |
N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine | Acrylamide | GAMA1 | 11.0 | |
N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine | Acrylonitrile | CYHA1 | 16.5 | |
N-Acetyl-S-(2-cyanoethyl)-L-cysteine | Acrylonitrile | CYMA1 | 12.3 | |
N-Acetyl-S- (2-carboxyethyl)-L-cysteine | Acrolein | CEMA1 | 12.8 | |
N-Acetyl-S- (3-hydroxypropyl)-L-cysteine | Acrolein | HPMA1 | 15.1 | |
N-Acetyl-S-(benzyl)-L-cysteine | Toluene* | BMA1 | 12.2 | |
Mandelic acid | Styrene | MADA1 | 21.4 | |
Phenylglyoxylic acid | Ethylbenzene/styrene | PHGA1 | 13.6 | |
N-Acetyl-S-(phenyl)-L-cysteine | Benzene | PMA1 | 17.3 | |
N-Acetyl-S- (2-hydroxypropyl)-L-cysteine | Propylene oxide | HPM21 | 10.1 | |
N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine | Dimethylformamide* | AMCA1 | 11.8 | |
N-Acetyl-S- (3,4-dihydroxybutyl)-L-cysteine | 1,3-Butadiene | DHBM1 | 11.5 | |
N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine | 1,3-Butadiene | MHB31 | 15.3 | |
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine | Crotonaldehyde | HPMM1 | 11.3 | |
N-Acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine | Isoprene | IPM31 | 17.1 | |
2-Thioxothiazolidine-4-carboxylic acid | Carbon disulfide | TTCA1 | 10.1 |
CV: Coefficient of variation
Multiple other parent chemicals can also be metabolized to these compounds.
Measured in all individuals
Measured only among those with a cotinine above 20 ng/mL.